SLDB

6.2702.64%
AG

Alexander G. Cumbo

President, CEO & Director

Mr. Alexander G. Cumbo, also known as Bo, serves as Director at Stoke Therapeutics, Inc. since September 2026. He has been Independent Director at Vor Biopharma Inc. since July 16, 2025. He is an Independent Director of Climb Bio, Inc. from March 2025. He serves as President, Chief Executive Officer and Director at Solid Biosciences Inc. since December 2, 2022. He has over many years of experience in the pharmaceutical and biotechnology industries, with a proven track record of leading successful commercial launches for 11 specialty and rare disease therapies. Mr. Cumbo served as an Independent Director of Verve Therapeutics, Inc. since June 2022 until July 25, 2025. He served as President, Chief Executive Officer and Director of AavantiBio, Incorporated from October 2020 to December 2022. He had been a Director at Ra Pharmaceuticals, Inc. since November 15, 2018. From January 2013 to October 2020, Mr. Cumbo held positions of increasing responsibility at Sarepta Therapeutics Inc., a precision genetic medicine company. He served as Chief Commercial Officer of Sarepta Therapeutics, Inc. since June 8, 2017 and as its Executive Vice President from February 2019 until October 2020. Prior to that, he was Senior Vice President of Sarepta Therapeutics, Inc. from June 8, 2017, until March 2019 and served as Senior Vice President of Global Commercial Development at Sarepta Therapeutics, Inc. from October 1, 2016, until June 8, 2017. Mr. Cumbo was the Head of Commercial and Vice President at Sarepta Therapeutics, Inc. until November 24, 2016 and served as its Vice President of Global Commercial Development since January 2013. Before joining Sarepta, Mr. Cumbo served as Vice President of Sales and Treatment Education at Vertex Pharmaceuticals from June 2010 to January 2013, where he played a key role in the launch of Incivek, one of the most successful drug launches in U.S. pharmaceutical history. Prior to Vertex, he worked for Gilead Sciences for nine years in multiple commercial roles supporting the HIV, HBV and Cardiovascular franchises. Mr. Cumbo has extensive experience in sales, marketing, national accounts, federal accounts, treatment education and commercial strategy, as well as in building effective teams for successful competitive launches. He started his career at GSK and has wide pharmaceutical and biotechnology experience, having led over ten specialty competitive launches during his career. He serves as a Board Member of Clinical Supplies Management, Inc. He holds a B.S. in Laboratory Technology from Auburn University.

Positions